Not applicableEnded earlyNCT04476537What this trial is testingRNA Precision Oncology in Advanced Pancreatic CancerWho this might be right forPancreatic Cancer Columbia University 16
Testing effectiveness (Phase 2)UnknownNCT00551577What this trial is testingNeoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical TrialWho this might be right forOvarian Neoplasms University Hospital, Bonn 100
Early research (Phase 1)Looking for participantsNCT06710379What this trial is testingADRX-0405 in Subjects With Select Advanced Solid TumorsWho this might be right forSolid Tumors Adcentrx Therapeutics 68
Early research (Phase 1)Study completedNCT02705482What this trial is testingEvaluate MEDI0562 in Combination With Immune Therapeutic Agents in Adult Subjects With Advanced Solid TumorsWho this might be right forSelect Advanced Solid Tumors MedImmune LLC 58
Large-scale testing (Phase 3)Looking for participantsNCT04892173What this trial is testingJNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCCWho this might be right forCarcinoma, Squamous Cell Johnson & Johnson Enterprise Innovation Inc. 500
Large-scale testing (Phase 3)Active Not RecruitingNCT06472076What this trial is testingBelrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)Who this might be right forLung Cancer, Non-Small Cell GlaxoSmithKline 88
Large-scale testing (Phase 3)Not Yet RecruitingNCT07730489What this trial is testingA Study Comparing BL-M07D1 With Physician's Choice Therapy in Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Failed Prior Treatment With Oxaliplatin, Fluorouracil and IrinotecanWho this might be right forColorectal Cancer Sichuan Baili Pharmaceutical Co., Ltd. 130
Early research (Phase 1)Study completedNCT01337765What this trial is testingSafety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor PatientsWho this might be right forUnspecified Adult Solid Tumor, Protocol SpecificSolid Tumor Pfizer 29
Not applicableLooking for participantsNCT07813000What this trial is testingPhysician and Patient Preferences for Cell Therapies in Advanced Solid TumorsWho this might be right forSolid Tumors Zhejiang University 1,020
Testing effectiveness (Phase 2)Study completedNCT03797326What this trial is testingEfficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)Who this might be right forAdvanced Solid TumorsTriple Negative Breast CancerOvarian Cancer+5 more Merck Sharp & Dohme LLC 611
Testing effectiveness (Phase 2)Active Not RecruitingNCT06120140What this trial is testingEnhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus LazertinibWho this might be right forCarcinoma, Non-Small-Cell Lung Janssen Research & Development, LLC 305
Large-scale testing (Phase 3)Study completedNCT03262935What this trial is testingSYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Byondis B.V. 437
Large-scale testing (Phase 3)Active Not RecruitingNCT06346067What this trial is testingAssess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)Who this might be right forAdvanced or Metastatic NRAS-mutant Melanoma Erasca, Inc. 78
Early research (Phase 1)Ended earlyNCT04234113What this trial is testingStudy of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsWho this might be right forThyroid CancerRenal Cell CarcinomaNon Small Cell Lung Cancer+16 more SOTIO Biotech AG 115
Early research (Phase 1)Looking for participantsNCT07807241What this trial is testingMX006 in Patients With Advanced and/or Metastatic Tumors Known to Express B7-H3Who this might be right forAdvanced and/or Metastatic Solid Tumors Known to Express B7-H3 Myricx Pharma Limited 120
Early research (Phase 1)Study completedNCT04659096What this trial is testingION537 in Patients With Molecularly Selected Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Ionis Pharmaceuticals, Inc. 15
Large-scale testing (Phase 3)Study completedNCT01721746What this trial is testingCompare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)Who this might be right forUnresectable or Metastatic Melanoma Bristol-Myers Squibb 405
Early research (Phase 1)Looking for participantsNCT07812805What this trial is testingSKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid TumorsWho this might be right forSelected Advanced Solid TumorsColorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+4 more SK Life Science, Inc. 100
Testing effectiveness (Phase 2)WithdrawnNCT01953536What this trial is testingSafety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)Who this might be right forBreast Neoplasms Endocyte
Testing effectiveness (Phase 2)Looking for participantsNCT03767075What this trial is testingA Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets)Who this might be right forAdvanced Solid Tumor Vall d'Hebron Institute of Oncology 1,000